Schwab\u00adm\u00fcn\u00adchen \u2014 A Gleiss Lutz team has advi\u00adsed the family-owned Ritter Group on the sale of the company to US tech\u00adno\u00adlogy group Avan\u00adtor. The purchase price is appro\u00adxi\u00adm\u00adately \u20ac890 million, subject to further payments depen\u00adding on the achie\u00adve\u00adment of certain perfor\u00admance-based mile\u00adsto\u00adnes. The tran\u00adsac\u00adtion is expec\u00adted to close in the 3rd quar\u00adter of 2021.<\/p>\n
Ritter<\/strong> is head\u00adquar\u00adte\u00adred in Schwab\u00adm\u00fcn\u00adchen, Germany, and is one of the fastest growing manu\u00adfac\u00adtu\u00adr\u00aders of high-quality consu\u00adma\u00adbles for liquid hand\u00adling, auto\u00adma\u00adted analy\u00adsis and clini\u00adcal test\u00ading, inclu\u00adding conduc\u00adtive pipette tips. These consu\u00adma\u00adbles are central to a variety of mole\u00adcu\u00adlar scree\u00adning and diagno\u00adstic appli\u00adca\u00adti\u00adons, inclu\u00adding real-time poly\u00adme\u00adrase chain reac\u00adtion (PCR), or as part of drug deve\u00adlo\u00adp\u00adment and clini\u00adcal trials for phar\u00admaceu\u00adti\u00adcal and Avan\u00adtor<\/strong> is a New York Stock Exch\u00adange-listed global leader in products and services used in key rese\u00adarch, deve\u00adlo\u00adp\u00adment and manu\u00adfac\u00adtu\u00adring acti\u00advi\u00adties by custo\u00admers in the high-tech\u00adno\u00adlogy, biotech\u00adno\u00adlogy, health\u00adcare and public sectors. Globally, the company serves 225,000 custo\u00admer sites and works with rese\u00adarch labo\u00adra\u00adto\u00adries and scien\u00adtists in more than 180 countries.<\/p>\n Advi\u00adsor Ritter: Gleiss Lutz<\/strong> Gleiss Lutz worked as lead coun\u00adsel with teams in various jurisdictions.<\/p>\n About Gleiss Lutz <\/strong><\/p>\n Gleiss Lutz regu\u00adlarly advi\u00adses family-owned compa\u00adnies on large-volume sales tran\u00adsac\u00adtions, inclu\u00adding the owners of ZKW on the sale of the company to the Korean tech\u00adno\u00adlogy group LG for EUR 1.1 billion or the owners of Getrag on the sale to Magna for EUR 1.75 billion.<\/p>\n","protected":false},"excerpt":{"rendered":" Schwab\u00adm\u00fcn\u00adchen \u2014 A Gleiss Lutz team has advi\u00adsed the family-owned Ritter Group on the sale of the company to US tech\u00adno\u00adlogy group Avan\u00adtor. The purchase price is appro\u00adxi\u00adm\u00adately \u20ac890 million, subject to further payments depen\u00adding on the achie\u00adve\u00adment of certain perfor\u00ad\u00admance-based mile\u00adsto\u00adnes. The tran\u00adsac\u00adtion is expec\u00adted to close in the 3rd quar\u00adter of 2021. Ritter is [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":37150,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-43496","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\n
\nBiotech\u00adno\u00adlogy Research.<\/p>\n
\nDr. Jochen Tyrolt<\/strong> (Part\u00adner, Stutt\u00adgart), Dr. Chris\u00adtian Cascante<\/strong> (Part\u00adner, Frank\u00adfurt, both Lead), Johan\u00adnes Schr\u00e4gle (Coun\u00adsel, Stutt\u00adgart), Dr. Patrick Moss\u00adler (Part\u00adner), Dr. Daniel Heck (Coun\u00adsel, both Hamburg), Florian Schorn (Munich), Dr. Lucas Hert\u00adneck, Nikolas
\nFrey (both Stutt\u00adgart, all M&A), Dr. Dirk Wasmann (Part\u00adner, Stutt\u00adgart), Dr. Thors\u00adten Gayk (Coun\u00adsel, Hamburg, both Corpo\u00adrate), Dr. Johann Wagner (Part\u00adner), Dr. Thomas B\u00fcche\u00adler (both Tax, Hamburg), Dr. Doris-Maria Schus\u00adter (Part\u00adner), Dr. Daniela Mayr (both Hamburg), Prof. Dr. Martin Diller (Part\u00adner), Dr. Sebas\u00adtian Ernst (both Stutt\u00adgart, all Labor Law), Dr. Alex\u00adan\u00adder Molle (Part\u00adner), Dr. Matthias Schilde, Jan Hinrichs (all IP\/IT), Dr. Chris\u00adtian Hamann (Part\u00adner), Simon Wegmann (both Data Protec\u00adtion Law), Dr. Enno Burk (Coun\u00adsel), Dr. Chris\u00adtina Fr\u00f6b
\n(both Health\u00adcare, all Berlin), Dr. Jacob von Andreae (Part\u00adner), Aylin Hoffs (both Foreign Trade Law, both D\u00fcssel\u00addorf), Dr. Moritz Holm-Hadulla (Part\u00adner), Dr. Andreas Sch\u00fcs\u00adsel (both Anti\u00adtrust), Dr. Simon Wagner (Coun\u00adsel, Dispute Reso\u00adlu\u00adtion, all Stutt\u00adgart), Frank Schlo\u00adb\u00adach (Part\u00adner), Dr. Thomas Kulzer (Coun\u00adsel, both Finance), Konrad Discher (Coun\u00adsel, Real Estate, all Frankfurt).<\/p>\n